Constitutive Regulation of Cardiac Fatty Acid Metabolism through Peroxisome Proliferator-activated Receptor α Associated with Age-dependent Cardiac Toxicity*
暂无分享,去创建一个
T. Ono | H. Fujii | Kenichi Watanabe | M. Kodama | Y. Aizawa | F. Gonzalez | T. Aoyama | T. Nakajima | M. Naito | G. Hasegawa | Y. Kamijo | Toshihiro Takahashi | Y. Ohta
[1] D. Kelly,et al. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[2] W. Wahli,et al. Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting , 1999 .
[3] R. Daynes,et al. Peroxisome Proliferator-activated Receptor α Activation Modulates Cellular Redox Status, Represses Nuclear Factor-κB Signaling, and Reduces Inflammatory Cytokine Production in Aging* , 1998, The Journal of Biological Chemistry.
[4] Kenichi Watanabe,et al. Myocardial CD36 expression and fatty acid accumulation in patients with type I and II CD36 deficiency , 1998, Annals of nuclear medicine.
[5] D. Kelly,et al. Fatty Acids Activate Transcription of the Muscle Carnitine Palmitoyltransferase I Gene in Cardiac Myocytes via the Peroxisome Proliferator-activated Receptor α* , 1998, The Journal of Biological Chemistry.
[6] K. Nakajima,et al. Myocardial fatty acid imaging with 123I-labelled 9-methyl-branched pentadecanoic acid (9MPA) using SPET. , 1998, Nuclear medicine communications.
[7] T. Aoyama,et al. Reversal of severe hypertrophic cardiomyopathy and excellent neuropsychologic outcome in very-long-chain acyl-coenzyme A dehydrogenase deficiency. , 1998, The Journal of pediatrics.
[8] W. Koenig,et al. Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators , 1998, Nature.
[9] J. Peters,et al. Altered Constitutive Expression of Fatty Acid-metabolizing Enzymes in Mice Lacking the Peroxisome Proliferator-activated Receptor α (PPARα)* , 1998, The Journal of Biological Chemistry.
[10] T. Hashimoto,et al. Medium Chain 3-Ketoacyl-Coenzyme A Thiolase Deficiency: A New Disorder of Mitochondrial Fatty Acid β-Oxidation , 1997, Pediatric Research.
[11] S. Im,et al. Constitutive activation of NF-kappa B in an animal model of aging. , 1997, International immunology.
[12] D. Kelly,et al. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. , 1996, Circulation.
[13] W. Wahli,et al. The PPARα–leukotriene B4 pathway to inflammation control , 1996, Nature.
[14] S. Hayashi,et al. Formation of the enzyme complex in mitochondria is required for function of trifunctional beta-oxidation protein. , 1996, Biochemical and biophysical research communications.
[15] William,et al. Purification of human very-long-chain acyl-coenzyme A dehydrogenase and characterization of its deficiency in seven patients. , 1995, The Journal of clinical investigation.
[16] T. Pineau,et al. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators , 1995, Molecular and cellular biology.
[17] J. Sakakibara,et al. Tissue-specific suppression of aortic fatty-acid-binding protein in streptozotocin-induced diabetic rats. , 1995, European journal of biochemistry.
[18] D. Moore,et al. The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[19] J. Balsinde,et al. Arachidonic acid mobilization in P388D1 macrophages is controlled by two distinct Ca(2+)-dependent phospholipase A2 enzymes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[20] H. Lodish,et al. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein , 1994, Cell.
[21] J. Tischfield,et al. Cloning and characterization of novel rat and mouse low molecular weight Ca(2+)-dependent phospholipase A2s containing 16 cysteines. , 1994, The Journal of biological chemistry.
[22] T. Hashimoto,et al. Rat very-long-chain acyl-CoA dehydrogenase, a novel mitochondrial acyl-CoA dehydrogenase gene product, is a rate-limiting enzyme in long-chain fatty acid beta-oxidation system. cDNA and deduced amino acid sequence and distinct specificities of the cDNA-expressed protein. , 1994, The Journal of biological chemistry.
[23] R. Kriz,et al. Delineation of two functionally distinct domains of cytosolic phospholipase A2, a regulatory Ca(2+)-dependent lipid-binding domain and a Ca(2+)-independent catalytic domain. , 1994, The Journal of biological chemistry.
[24] R. Wanders,et al. Mitochondrial trifunctional protein deficiency. Catalytic heterogeneity of the mutant enzyme in two patients. , 1994, The Journal of clinical investigation.
[25] H. Taegtmeyer. Energy metabolism of the heart: from basic concepts to clinical applications. , 1994, Current problems in cardiology.
[26] T. Hashimoto,et al. Molecular cloning of the cDNAs for the subunits of rat mitochondrial fatty acid beta-oxidation multienzyme complex. Structural and functional relationships to other mitochondrial and peroxisomal beta-oxidation enzymes. , 1993, The Journal of biological chemistry.
[27] P. Grimaldi,et al. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. , 1993, The Journal of biological chemistry.
[28] T. Aoyama,et al. A novel disease with deficiency of mitochondrial very-long-chain acyl-CoA dehydrogenase. , 1993, Biochemical and biophysical research communications.
[29] T. Fujimoto. Calcium pump of the plasma membrane is localized in caveolae , 1993, Journal of Cell Biology.
[30] J. Capone,et al. Identification of a peroxisome proliferator-responsive element upstream of the gene encoding rat peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[31] D. Berman,et al. Comparison of myocardial imaging with iodine-123-iodophenyl-9-methyl pentadecanoic acid and thallium-201-chloride for assessment of patients with exercise-induced myocardial ischemia. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[32] I. Issemann,et al. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators , 1990, Nature.
[33] J. Kondo,et al. Structure and regulation of rat long-chain acyl-CoA synthetase. , 1990, The Journal of biological chemistry.
[34] K. Tanaka,et al. Molecular cloning and nucleotide sequence of cDNAs encoding the precursors of rat long chain acyl-coenzyme A, short chain acyl-coenzyme A, and isovaleryl-coenzyme A dehydrogenases. Sequence homology of four enzymes of the acyl-CoA dehydrogenase family. , 1989, The Journal of biological chemistry.
[35] F. Spener. Fatty Acid Metabolism and its Regulation , 1985 .
[36] P. Poole‐Wilson,et al. Hypoxia and calcium. , 1979, Journal of molecular and cellular cardiology.
[37] Hashimoto Takashi,et al. Effects of administration of di-(2-ethylhexyl)phthalate on rat liver mitochondria. , 1978 .
[38] J. Oram,et al. Myocardial utilization of carbohydrate and lipids. , 1972, Progress in cardiovascular diseases.
[39] P. Schollmeyer,et al. Substrate-utilization of the Human Kidney , 1966, Nature.